Oculus Innovative Sciences (OCLS) Tops Q2 EPS by 14c

Go back to Oculus Innovative Sciences (OCLS) Tops Q2 EPS by 14c

Oculus Innovative Sciences Reports Financial Results for the Fourth Quarter of Fiscal Year 2015

June 11, 2015 4:05 PM EDT

Total revenue increased 37% to $4 million from $2.9 million in the same period last year; up 25% from the quarter ending December 31, 2014 Cash as of March 31, 2015 of $6.1 million and debt free Upon completion of Ruthigen merger, Oculus will receive an additional $4.5 million from the sale of Ruthigen shares Company strategy to expand footprint in U.S. dermatology is on track: sales in the fourth quarter grew to $412,000, up $302,000 from the same period last year Conference call begins at 4:30 p.m. EDT today

PETALUMA, Calif., June... More